Video 2: MDT perspectives on communicating ADC treatment toxicities to patients with metastatic breast cancer episode artwork

EPISODE · Mar 31, 2025 · 13 MIN

Video 2: MDT perspectives on communicating ADC treatment toxicities to patients with metastatic breast cancer

from touchPODCAST · host touchpodcast

Listen to key experts from a multidisciplinary team discuss effective strategies for communicating the potential side effects associated with ADC treatment to patients with metastatic breast cancer. The multidisciplinary team Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France Nurse practitioner: Dr Kayla Freeman, Emory Winship Cancer Institute, Atlanta, GA, USA Patient advocate: Mrs Lesley Turner, Independent Cancer Patients’ Voice, UK This touchPODCAST is for HCPs outside of the UK only.  This activity is funded by an independent medical education grant from Gilead Sciences, Inc. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchONCOLOGY.com

Episode metadata supplied by the publisher feed · Published Mar 31, 2025

Embed this episode

Ready to play

Video 2: MDT perspectives on communicating ADC treatment toxicities to patients with metastatic breast cancer

0:00 13:03

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of touchPODCAST?

This episode is 13 minutes long.

When was this touchPODCAST episode published?

This episode was published on March 31, 2025.

Can I download this touchPODCAST episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!